Conference abstract · 25 Aug 2015
Conference abstractPublished 4 Aug 2015
Drug development targeting cancer stem cells
StemTek, Therapeutics, Spain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Conventional anti-cancer treatment excels at tumor size reduction leading to clinically evident responses. However, these effects are frequently transient and are not associated with increased patient survival. Treatments are often too toxic to normal cells and they fail to selectively kill cancer stem cells (CSCs), which can survive treatment and, like the queen bee of a beehive, give rise to new malignant cells. Therefore CSCs are an underlying cause of tumor recurrence and metastasis. For truly effective treatments that can create a durable clinical response drugs that can target CSCs must be developed. Here we present data showing how functional assays for drug screening may be used to unravel compounds that target cancer stem cells, with a case study on drugs that inhibit activation of HIF dependent pathways
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 15 Jan 2017
Dysadherin is highly expressed in ovarian cancer side population and plays important role in drug resistance of ovary cancer stem cells
Conference abstract · 24 Nov 2016
E-BABE- Multitheranostic nanocapsule encapsulated with multiple drugs and Gd-neutron capture therapy facilitated by stem cell-magneto-based targeting for GBM
Perspective · 29 May 2025
Targeting cancer stem cells: A new frontier in molecular oncology research
Conference abstract · 15 Oct 2018
Cancer stem cells (CSC), genetic drivers and therapeutic targeting via CCR5
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- SubjectOncology & Cancer
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Angel Garcia Martin”
